A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen
Clinical trial NCT05769608 · COMPLETED
Trial details
- NCT number
- NCT05769608
- Sponsor
- Mineralys Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-13
- Primary completion
- 2025-01-15
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.